Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
Personalized GLP-1 Weight Loss Plan Our team uses advanced body composition analysis and RMR (Resting Metabolic Rate) testing to create a customized weight loss program that preserves muscle while targeting fat, ensuring long-term results Real People
for example, if your ferritin (iron stores) is low, your thyroid medication may not work effectively
Why cant I shake the vial to mix the peptide
She notes that its crucial to choose a platform that clearly explains what a microdosing program actually looks likeboth in terms of expected results (think: steadier, slower progress, not the rapid weight loss that comes with standard dosing) and the day-to-day process of titrating responsibly
your PlexusDx provider monitors you throughout treatment
